
MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is... MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.24 | -11.4285714286 | 2.1 | 2.14 | 1.77 | 155451 | 1.88744624 | CS |
4 | -0.3 | -13.8888888889 | 2.16 | 2.3 | 1.73 | 401190 | 1.98430869 | CS |
12 | -0.41 | -18.0616740088 | 2.27 | 2.63 | 1.73 | 332708 | 2.108872 | CS |
26 | -0.87 | -31.8681318681 | 2.73 | 3.6981 | 1.73 | 212598 | 2.35995229 | CS |
52 | 0.33 | 21.568627451 | 1.53 | 5.99 | 1.24 | 274861 | 2.69444975 | CS |
156 | -2.24 | -54.6341463415 | 4.1 | 9.64 | 0.82 | 236462 | 3.22668745 | CS |
260 | -2.24 | -54.6341463415 | 4.1 | 9.64 | 0.82 | 236462 | 3.22668745 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.